# A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer

> **NCT00385970** · PHASE3 · UNKNOWN · sponsor: **Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group** · enrollment: 380 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Tegafur-uracil (UFT)
- **DRUG:** Calcium folinate (LV)
- **DRUG:** Krestin (PSK)

## Key facts

- **NCT ID:** NCT00385970
- **Lead sponsor:** Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2012-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385970, "A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00385970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*